NYEE HomeThe New York Eye and Ear Infirmary
Patient InfoHealthcare ProfessionalsSpecialties & ServicesSupport NYEEAbout Us
  Current Research
Clinical Trials in Ophthalmology
Ophthalmology
Research

Otolaryngology
Research

Pathology
& Laboratory Medicine
Research

Plastic &
Reconstructive
Surgery
Research

Institutional
Review Board
(IRB)

 
printer-friendly version of this pagePrinter-Friendly Page large print version of this pageLarge Print Version 

A Phase II Multicenter, Randomized, Double-Masked, Placebo-Controlled, Dose-Comparison Study of the Safety and Efficacy of Fenretinide in the Treatment of Geographic Atrophy in Subjects With Age-Related Macular Degeneration


Principal Investigator: Richard Rosen, MD

Enrollment Status: Open Enrollment

Objective:  This is a Phase II multicenter, randomized, double-masked, placebo-controlled, dose-comparison study of the safety and efficacy of fenretinide in the treatment of Geographic Atrophy in subjects with AMD. Subjects will be given PreserVision® Lutein Soft Gels Eye Vitamins, without beta-carotene, to take throughout the study.

Eligibility: 

Contact Information:  Anita Ou, CRC (212) 979-4672; Jenny Gallardo, CRC (212)-614-8386; Katy Tai, CR Manager (212) 979-4251

 

Home > Current Research > Clinical Trials in Ophthalmology > A PHASE II MULTICENTER, RANDOMIZED, DOUBLE-MASKED, PLACEBO-CONTROLLED, DOSE-COMPARISON STUDY OF THE SAFETY AND EFFICACY OF FENRETINIDE IN THE TREATMENT OF GEOGRAPHIC ATROPHY IN SUBJECTS WITH AGE-RELATED MACULAR DEGENERATION